We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
43 hedge funds and large institutions have $305M invested in Larimar Therapeutics in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
48% more capital invested
Capital invested by funds: $206M → $305M (+$99.1M)
38% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 8
13% more funds holding
Funds holding: 38 → 43 (+5)
4.08% more ownership
Funds ownership: 88.7% → 92.79% (+4.1%)
Holders
43
Holders Change
+5
Holders Change %
+13.16%
% of All Funds
0.76%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.09%
New
11
Increased
11
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
+$7.72M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.81M |
| 3 |
BlackRock
New York
|
+$3.11M |
| 4 |
JGC
J. Goldman & Co
New York
|
+$1.45M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.42M |
